Scopio Labs, founded in 2015 by CEO Itai Hayut and Erez Na’aman, develops next-generation digital microscopes, based on computational imaging breakthroughs, as well as a suite of dedicated image analysis tools. Their products enable dramatic clinical and research improvements in diverse areas such as cancer, hematology and cytology, while powering further innovation in areas such as academic research and drug discovery. The company will use the funds to expand the team based in Tel Aviv, and is hiring computer vision experts, physicists and software developers.

Read more on Globes here.